Related Experiment Video
Updated: May 2, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7
Wei A He1, Federica Calore, Priya Londhe
1Department of Molecular Virology, Immunology, and Medical Genetics, Human Cancer Genetics Program, and the Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
Abstract:
MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene expression and, in cancers, are often packaged within secreted microvesicles. The cachexia syndrome is a debilitating state of cancer that predominantly results from the loss of skeletal muscle mass, which is in part associated with apoptosis. How tumors promote apoptosis in distally located skeletal muscles has not been explored. Using both tumor cell lines and patient samples, we show that tumor-derived microvesicles induce apoptosis of skeletal muscle cells. This proapoptotic activity is mediated by a microRNA cargo, miR-21, which signals through the Toll-like 7 receptor (TLR7) on murine myoblasts to promote cell death. Furthermore, tumor microvesicles and miR-21 require c-Jun N-terminal kinase activity to regulate this apoptotic response. Together, these results describe a unique pathway by which tumor cells promote muscle loss, which might provide a great insight into elucidating the causes and treatment options of cancer cachexia.
Insights
Tumor cells release microvesicles containing microRNA-21 (miR-21), which induce skeletal muscle cell death. This pathway, involving Toll-like receptor 7 (TLR7) and c-Jun N-terminal kinase, contributes to cancer cachexia and muscle loss.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Cancer cachexia involves significant skeletal muscle mass loss, partly due to apoptosis.
- The mechanisms by which tumors induce apoptosis in distant skeletal muscles remain largely unexplored.
Purpose of the Study:
- To investigate how tumors induce apoptosis in skeletal muscle cells.
- To identify the molecular mediators responsible for tumor-induced muscle wasting.
Main Methods:
- Utilized tumor cell lines and patient samples.
- Analyzed the role of tumor-derived microvesicles and specific microRNAs (miRNAs).
- Investigated signaling pathways including Toll-like receptor 7 (TLR7) and c-Jun N-terminal kinase (JNK).
Main Results:
- Tumor-derived microvesicles were shown to induce apoptosis in skeletal muscle cells.
- MicroRNA-21 (miR-21) within these microvesicles mediates the proapoptotic effect.
- The miR-21/TLR7 pathway and JNK activity are crucial for this tumor-induced muscle cell death.
Conclusions:
- A novel pathway is described where tumor cells promote muscle loss via secreted microvesicles carrying miR-21.
- This finding offers insights into the pathogenesis of cancer cachexia.
- Identified potential targets for therapeutic interventions against cancer-related muscle wasting.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment